Anthonly S.  Marucci net worth and biography

Anthonly Marucci Biography and Net Worth

President & CEO of Celldex Therapeutics
Mr. Marucci was appointed President and Chief Executive Officer of Celldex in September 2008 and as a director of Celldex in December 2008. Since May 2003, Mr. Marucci has held a number of roles with Celldex, including as a founder, Vice President, Chief Financial Officer, Treasurer and Secretary. In addition, he was Treasurer of Medarex, Inc. (now a part of Bristol-Myers Squibb Co.) from December 1998 to March 2004. Mr. Marucci held a series of senior financial positions at Medarex from December 1998 to May 2003. Since May 2021, Mr. Marucci serves as a member of the board of directors of Genenta Science S.p.A., a publicly held biopharmaceutical company. Mr. Marucci is a member of the Board of Trustees of BioNJ Inc. and also served as its Treasurer through 2010. Mr. Marucci is also a member of the Board of the College of Business and Public Management at Kean University. Mr. Marucci received his M.B.A. from Columbia University and his M.H.L. from Brown University.

How do I contact Anthonly S. Marucci?

The corporate mailing address for Mr. Marucci and other Celldex Therapeutics executives is 53 FRONTAGE ROAD SUITE 220, HAMPTON NJ, 08827. Celldex Therapeutics can also be reached via phone at (908) 454-7120 and via email at [email protected]. Learn More on Anthonly S. Marucci's contact information.

Has Anthonly S. Marucci been buying or selling shares of Celldex Therapeutics?

Anthonly S. Marucci has not been actively trading shares of Celldex Therapeutics in the last ninety days. Learn More on Anthonly S. Marucci's trading history.

Who are Celldex Therapeutics' active insiders?

Celldex Therapeutics' insider roster includes Sarah Cavanaugh (SVP), Elizabeth Crowley (VP), Freddy Jimenez (SVP), Samuel Martin (CFO), Anthonly Marucci (President & CEO), and Diane Young (SVP). Learn More on Celldex Therapeutics' active insiders.

Anthonly S. Marucci Insider Trading History at Celldex Therapeutics

See Full Table

Anthonly S. Marucci Buying and Selling Activity at Celldex Therapeutics

This chart shows Mr. Anthony S. Marucci M.B.A.'s buying and selling at Celldex Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Celldex Therapeutics Company Overview

Celldex Therapeutics logo
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.
Read More

Today's Range

Now: $36.30
Low: $35.65
High: $36.74

50 Day Range

MA: $42.07
Low: $36.26
High: $51.88

2 Week Range

Now: $36.30
Low: $22.11
High: $53.18

Volume

324,928 shs

Average Volume

876,565 shs

Market Capitalization

$2.03 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.49